Greg Chow

Greg Chow is a seasoned financial executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Chief Financial Officer at Sutro Biopharma, Inc. since June 2025, Greg has held prior leadership positions including Chief Financial and Business Officer at NodThera and Chief Financial Officer at Freenome. Additionally, Greg played a key role as Chief Financial Officer at Frontier Medicines from March 2021 to January 2024 and as Executive Vice President and Chief Financial Officer at Aptose Biosciences, Inc. from November 2013 to March 2021. Greg Chow holds a BA in Business Economics with a focus on Accounting from UC Santa Barbara and an MBA in Finance from The Wharton School.